Larimar Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Bala Cynwyd, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Larimar Therapeutics, Inc. has filed 693 SEC EDGAR filings since 28 Aug 2006

SEC filing history

Showing 1-25 of 690 matching filings.

Per page
25
Current page
1
4

4

Filing date
08 Jul 2026
Reporting date
06 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 May 2026
Reporting date
19 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 May 2026
Reporting date
19 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 May 2026
Reporting date
19 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 May 2026
Reporting date
19 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 May 2026
Reporting date
19 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 May 2026
Reporting date
19 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88225

SCHEDULE 13G/A filing

Filing date
14 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88225

SCHEDULE 13G/A filing

Filing date
30 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-36510

ARS

Filing date
20 Apr 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36510

DEF 14A

Filing date
20 Apr 2026
Reporting date
17 Apr 2026
Next action
Verify source filing
PRE 14A File 001-36510

PRE 14A

Filing date
10 Apr 2026
Reporting date
19 May 2026
Next action
Verify source filing
SCHEDULE 13D/A File 005-88225

SCHEDULE 13D/A filing

Filing date
02 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Mar 2026
Reporting date
27 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
02 Mar 2026
Reporting date
27 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .